LO SIMPESSE
DEAD

Serial Number

97757004

Owner

Aurobindo Pharma Ltd

Attorney

Adam Rodriguez

Filing Date

Jan 17, 2023

Add to watchlist:

No watchlists yet
View on USPTO

LO SIMPESSE Trademark

Serial Number: 97757004

LO SIMPESSE is a trademark filed by Aurobindo Pharma Ltd on January 17, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Aurobindo Pharma Ltd (66 trademarks)

Plot No. 2, Maitrivihar, Ameerpet
Hyderabad 500038 , IN

Entity Type: 03

Trademark Details

Filing Date

January 17, 2023

Registration Date

Not Registered

Published for Opposition

January 30, 2024

Goods & Services

Contraceptive preparations

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 28, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 28, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 12, 2024 EXRA
SOU EXTENSION 1 GRANTED
Dec 12, 2024 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 12, 2024 AITU
SOU EXTENSION RECEIVED WITH TEAS PETITION
Sep 27, 2024 TPEX
NOTICE OF REVIVAL - E-MAILED
Sep 27, 2024 NREV
PETITION TO REVIVE-GRANTED
Sep 27, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Sep 27, 2024 PROA
SOU EXTENSION 1 FILED
Sep 26, 2024 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 26, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 30, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 30, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 10, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 27, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 27, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 27, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 27, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 27, 2023 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 17, 2023 GNRN
NON-FINAL ACTION E-MAILED
Oct 17, 2023 GNRT
NON-FINAL ACTION WRITTEN
Oct 17, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 14, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 7, 2023 NWOS
NEW APPLICATION ENTERED
Jan 20, 2023 NWAP